Navigation Links
drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
Date:2/6/2008

Core OTC cost of sales $45,342 $40,484 $164,235 $139,562

Gross profit 20,492 15,569 69,813 58,290

CNS 414 476 1,647 2,264

Core OTC gross profit $20,078 $15,093 $68,166 $56,026

Gross margin 31.1% 27.8% 29.8% 29.4%

CNS 92.0% 91.2% 87.6% 95.3%

Core OTC gross margin 30.7% 27.2% 29.3% 28.6%

Variable order costs $6,479 $5,456 $22,259 $18,650

CNS 144 161 607 711

Core OTC variable

order costs $6,335 $5,295 $21,652 $17,939

Contribution margin 14,013 10,113 47,554 39,640

CNS 270 315 1,040 1,553

Core OTC contribution

margin $13,743 $9,798 $46,514 $38,087

NOTE 3: Supplemental information related to the company's Core OTC net

sales, cost of sales, gross profit, gross margin, variable order

costs and contribution margin for the three and twelve months

ended December 30, 2007 and December 31, 2006 is presented for

informational purposes only and is not prepared in accordance with

generally accepted accounting principles. On December 31, 2005,

we entered into a fulfillment agreement with Weil Lifestyles, LLC,

resulting in Weil-related CNS net sales (which make up the

substantial majority of CNS net sales) being recorded on a net

basis after that date. All CNS sales were previously recorded on a

gross basis.

SUPPLEMENTAL INFORMATION: Segment Information:


'/>"/>

SOURCE drugstore.com, inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
2. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
3. drugstore.com and Revolution Health Group Announce Breakthrough Deal
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Joint Commission International Achieves Accreditation from ISQua
6. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
7. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
8. Pharsight Achieves $7.3 Million in Quarterly Revenue
9. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
10. LMS integrated obstetrics solution achieves general availability
11. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)... Dec. 1 Medication therapy managem...ccomplished professionals to its,advisory board. ... include Martin Makary, M.D.;,Michael Burcham; an... of,advisors that has helped PharmMD launch and h... medication error, misuse, overuse and abuse. MTM...
(Date:12/1/2008)...Dec. 1 The United State...is new right hand on Saturday, November 29, as Dr....on, changed the bandages. , , "Wow, it look...from his room at Jewish Hospital. "It,s awesome,"... , Hondusky, a New York resident, went on to ...
(Date:12/1/2008)...he implant makes it more difficult to treat the ma...c. 1 (HealthDay News) -- Women who have had their ...nosed with early-stage breast cancer may be treate...atment known as brachytherapy, according to an Ari...hallenge to take care of these augmented women," s...
(Date:12/1/2008)...Dec. 1 /PRNewswire-USNewswire/ -- As part of the...tary of Health Everette James today urged Pennsylv...s AIDS. He also highlighted ongoing efforts to edu...evented. , , "Our message is clear: regardl... race, being tested for HIV is the only sure way t...
Breaking Medicine News(10 mins):Health News:PharmMD Expands Advisory Board 2Health News:Fifth U.S. Hand Transplant Patient Gets Look at New Hand 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 3Health News:PA Department of Health Recognizes 20th Anniversary of World AIDS Day; Urges HIV Testing 2
...hers the appropriate treatment should be recommend...uce the complications. Women who have// had breast...ose who have chemotherapy and tamoxifen may have r...niversity of Cleavland report on one of the larges...
... had approved Elidel ( pimecrolimus ) cream for tr...n called atopic dermatitis, or eczema. The skin co... rashes that often seep and ooze. The drug maker, ...eople in the U.S. develop flare-ups of eczema. // ...
...tudy a diet high in animal products raises the ris...s protection. Many studies have suggested a link b...nd breast cancer.// An independent researcher base...es might explain the geographical variation in bre...
... easy painfree way to detect oral cancer at its ea...ich underwent clinical trials at the University of...ed it to be a significant advance over previous cy...g to Martin S. Greenberg, professor and chairman o...
Other Medicine News:
(Date:11/27/2008)... New study finds the majority of acute lymphoblas...dy present at the time of diagnosis , , MEM...ientists at St. Jude Children,s Research Hospital ... cancer cells of children with acute lymphoblastic...fers a pathway to designing treatments for ALL rel...
(Date:11/25/2008)... LOUISVILLE, Ky., Nov. 25 /PRNewswire-USNewswire/...and surgeons performed the fifth U.S. hand transpl...usky, at Louisville,s Jewish Hospital Hand Care Ce...dure began around noon and was completed shortly a...oto: http://www.newscom.com/cgi-bin/prnh/2008112...
(Date:11/25/2008)... 200 Patients Enrolled in Clinical Trial to Asses...ard of Care Therapies for Unresectable Hepatocellu... Light Sciences Oncology, Inc. (LSO...a global Phase 3 clinical trial of Light Infusion ...able hepatocellular carcinoma (HCC), also known as...
(Date:11/24/2008)... november is Pancreatic Cancer Awareness Month ,...wswire/ -- The American Society for Gastrointesti...ion Network are teaming up this November to raise ...nts about the disease and the resources that are a... the fourth leading cause of cancer deaths in the ...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6McGraw Wentworth Launches Survey to Benchmark Employee Benefit Trends in Michigan 12032 1McGraw Wentworth Launches Survey to Benchmark Employee Benefit Trends in Michigan 12032 2Hypoglycemia Alert Dogs Offer Assistance to People with Diabetes 12029 1Hypoglycemia Alert Dogs Offer Assistance to People with Diabetes 12029 2Hypoglycemia Alert Dogs Offer Assistance to People with Diabetes 12029 3CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference 12026 1CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference 12026 2Viral Therapy Slows Pediatric Tumors in Mice 12024 1Viral Therapy Slows Pediatric Tumors in Mice 12024 2
...ption Pain,Reliever to Health Care Professionals ...nd Drug,Administration,s (FDA) Office of Criminal ...ue Frederick Company, Inc. has agreed,to pay more ...civil,liabilities in connection with several illeg...a powerful prescription pain reliever,that the com...
...Innovations and a Health Conscious,Public?, WASHIN...e Food,and Drug Administration (FDA) must adapt to...althcare, Commissioner Andrew von,Eschenbach told ...h,Annual Conference April 12 in Bethesda, Md. , FD...mited,financial and personnel resources to deal wi...
Other Medicine Technology:FDA Announces Results of Investigation Into Illegal Promotion of,OxyContin by The Purdue Frederick Company, Inc. 2FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,FDA Regulations 2
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
...ories is a national reference laboratory and a wor...d development. ARUP offers an extensive test menu ...ical and anatomic pathology. Owned by the Universi...e than half of the nation's university teaching ho...
Medicine Products: